In vitro to clinical translational pharmacokinetic/pharmacodynamic modeling of doxorubicin (DOX) and dexrazoxane (DEX) interactions: Safety assessment and optimization
Crossref DOI link: https://doi.org/10.1038/s41598-023-29964-4
Published Online: 2023-02-22
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mody, Hardik
Vaidya, Tanaya R.
Ait-Oudhia, Sihem
Text and Data Mining valid from 2023-02-22
Version of Record valid from 2023-02-22
Article History
Received: 19 August 2022
Accepted: 14 February 2023
First Online: 22 February 2023
Competing interests
: The authors declare no competing interests.